iBio, Inc. (IBIO) › Cash & EquivalentsiBio, Inc. (IBIO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $909.9K2011: $2.84M2012: $5.62M2013: $4.41M2014: $3.59M2015: $9.49M2016: $15.93M2017: $15.93M2018: $4.42M2019: $4.42M2020: $55.11M2021: $77.40M2022: $22.68M2023: $4.30M2024: $14.21M2025: $8.58M$8.58M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.58M-39.6%2024$14.21M+230.4%2023$4.30M-81.0%2022$22.68M-70.7%2021$77.40M+40.4%2020$55.11M+1146.6%2019$4.42M+0.0%2018$4.42M-72.3%2017$15.93M+0.0%2016$15.93M+67.8%2015$9.49M+164.5%2014$3.59M-18.7%2013$4.41M-21.5%2012$5.62M+97.8%2011$2.84M+212.4%2010$909.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share